• Morgan Stanley sets a price target of $174 for Humana, indicating a potential decrease of about -10.86% from the current price.
• Tejara Capital Ltd acquires 7,200 shares of Humana, showing confidence in the company's long-term potential despite a slight decrease in stock price.
• Other hedge funds, including Elevation Point Wealth Partners LLC and Mather Group LLC, have made new investments in Humana, highlighting continued interest in the health insurance giant.

Humana Inc. (NYSE:HUM) is a prominent player in the health insurance industry, providing a range of health, wellness, and insurance services. On February 2, 2026, Morgan Stanley set a price target of $174 for Humana, while the stock was trading at $195.20. This target suggests a potential decrease of about -10.86% from the current price.

Despite Morgan Stanley's downgrade, Tejara Capital Ltd has shown confidence in Humana by acquiring 7,200 shares valued at approximately $1.87 million. This move indicates a belief in the company's long-term potential, even as the stock price experiences a slight decrease of 0.75%, or $1.47, to $195.20.

Other hedge funds are also adjusting their positions in Humana. Elevation Point Wealth Partners LLC and Mather Group LLC have acquired new positions valued at around $32,000 and $34,000, respectively. Private Wealth Management Group LLC increased its holdings by 47.5% in the third quarter, now owning 149 shares valued at $39,000.

The stock has shown volatility, with today's price fluctuating between $192.40 and $197.34. Over the past year, Humana's stock has reached a high of $315.35 and a low of $191.39. The company's market capitalization stands at approximately $23.48 billion, with a trading volume of 3,220,371 shares on the NYSE.